Large-scale integration of the plasma proteome with genetics and disease
By E. Ferkingstad, P. Sulem, Bjarni A Atlason, G. Sveinbjornsson, Magnus I. Magnusson, Edda L. Styrmisdottir, Kristbjorg Gunnarsdottir, Agnar Helgason, A. Oddsson, Bjarni V. Halldórsson and 30 more. Nature Genetics, 2021
1,317 citations recorded by the source corpus.
Subfields: Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/43de944f803d0acf0cd888b8e0b183e90d4bb456
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Molecular Biology
Citations in the corpus
- Measuring biological age using omics data (2022, background): “Although the SomaLogic aptamer-based platform is especially powerful and can reliably quantify over 7,000 proteins in a variety of biofluids and cellular extracts 103–106 , it is not yet possible to reliably quantify the entire proteome.”
- Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets (2023, neutral): “We also tested our significant pQTLs for replication in 35,556 Icelanders from the deCODE study 9 , which assayed plasma proteins using the aptamer-based SomaS-can platform (Supplementary Note 2).”
- Plasma proteomic associations with genetics and health in the UK Biobank (2023, methodology): “…contributions from significant independent pQTLs identified by SuSiE (pQTL component) and the remaining SNPs across the genome (excluding the pQTL region), which assumes a polygenic model (polygenic component) using an approach that was described previously 32 (Methods and Supplementary Table 19).”